Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 413-420

  Dignam, James J ^a   Ye, Yunrong ^a   Colangelo, Linda ^a   Smith, Roy ^a   Mamounas, Eleftherios P ^a   Wieand, H Samuel ^a   Wolmark, Norman ^a  

^a University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; TREATMENT PLANNING; AGED; CAUCASIAN; COMPARATIVE STUDY; DISEASE COURSE; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; MALE; MIDDLE AGED; NEGRO; PATHOLOGY; RECTUM TUMOR; RISK; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037317435     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.02.004     Document Type: Article

References (67)

1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 52:23-47, 2002
2. Ries LAG, Eisner MP, Kosary CL, et al (eds): SEER Cancer Statistics Review, 1973-1997. Bethesda, MD, National Cancer Institute, 2000
3. Kockerling F, Reymond MA, Altendorf-Hofmann A, et al: Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 16:324-329, 1998
4. Porter GA, Soskolne CL, Yakimets WW, et al: Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157-167, 1998
5. Abulafi AM, Williams NS: Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7-19, 1994
6. Hermanek P, Mansmann U, Staimmer DS: The German experience: The surgeon as a prognostic factor in colon and rectal cancer surgery. Surg Oncol Clin N Am 9:33-49, 2000
7. Stocchi L, Nelson H, Sargent DJ, et al: Impact of surgical and pathologic variables in rectal cancer: A United States community and cooperative group report. J Clin Oncol 19:3895-3902, 2001
8. Tepper JE, O'Connell MJ, Niedzwiecki D, et al: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157-163, 2001
9. 0 rectal cancer: Do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167-173, 1999
10. Brodsky JT, Richard GK, Cohen AM, et al: Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 69:322-326, 1992
11. Blumberg D, Paty PB, Picon AI, et al: Stage I rectal cancer: Identification of high-risk patients. J Am Coll Surg 186:574-579, 1998
12. Jatzko GR, Jagoditsch M, Lisborg PH, et al: Long-term results of radical surgery for rectal cancer: Multivariate analysis of prognostic factors influencing survival and local recurrence. Eur J Surg Oncol 25:284-291, 1999
13. Tepper JE, O'Connell MJ, Niedzwiecki JS, et al: Final report of INT 0114-Adjuvant therapy in rectal cancer: Analysis by treatment, stage, and sex. Proc Am Soc Clin Oncol 20:123a, 2001 (abstr 489)
14. Johnston PG, Fisher ER, Rockette HE, et al: The role of thymidylate synthase expression in prognosis and outcome to adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12:2540-2647, 1994
15. 0 colorectal carcinoma: Implications for adjuvant chemotherapy. Cancer 83:1081-1085, 1998
16. Jernvall P, Markinen MJ, Karttynen TJ, et al: Microsatellite instability: Impact on cancer progression in proximal and distal colorectal cancer. Eur J Cancer 35:197-201, 1999
17. Dawson LA, Franssen E, Davey P: Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy. Cancer J Sci Am 5:374-379, 1999
18. Wiggenraad R, Tamminga R, Blok P, et al: The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 41:29-35, 1998
19. Compton CC, Fielding LP, Burgart LJ, et al: Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979-994, 2000
20. Godwin II JD, Brown CC: Some prognostic factors in survival of patients with cancer of the colon and rectum. J Chronic Dis 28:441-454, 1975
21. Beart RW, Steele GD Jr, Menck HR, et al: Management and survival of patients with adenocarcinoma of the colon and rectum: A national survey of the commission on cancer. J Am Coll Surg 181:225-236, 1995
22. Cooper GS, Yuan Z, Landefeld CS, et al: The performance of and survival after surgery for colorectal cancer: race-related differences among Medicare beneficiaries. Am J Public Health 86:582-586, 1996
23. Mandelblatt J, Andrews H, Kao R, et al: The late-stage diagnosis of colorectal cancer: Demographic and socioeconomic factors. Am J Public Health 86:1794-1797, 1996
24. Yancik R, Wesley MN, Ries LA, et al: Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer 82:2123-2134, 1998
25. Wichmann MW, Muller C, Hornung HM, et al: Gender differences in long term survival of patients with colorectal cancer. Br J Surg 88:1092-1098, 2001
26. Young JL Jr, Ries LG, Pollack ES: Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 73:341-352, 1984
27. Baquet CR, Ringen K: Cancer among blacks and other minorities: Statistical profiles. Bethesda, MD, National Cancer Institute, NIH publication 86-2785, 1986
28. Miller BA, Kolonel LN, Bernstein L, et al, (eds): Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda, MD, NIH Publication 96-4104, 1996
29. Dayal H, Polissar L, Yang CY, et al: Race, socioeconomic status, and other prognostic factors for survival from colorectal cancer. J Chronic Dis 40:857-864, 1987
30. Michelassi F, Block GE, Vannucci L, et al: A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 208:379-389, 1988
31. Ragland KE, Selvin S, Merrill, DW: Black-white differences in stage-specific cancer survival: Analysis of seven selected sites. Am J Epidemiol 133:672-682, 1991
32. Dignam JJ, Colangelo L, Tian W, et al: Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst 91:1933-1940, 1999
33. Bearhs OH, Henson DE, Hutter RVP, et al (eds): American Joint Committee on Cancer: Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992
34. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988
35. Wolmark N, Wieand HS, Hyams DM, et al: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project protocol R-02. J Natl Cancer Inst 92:388-396, 2000
36. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
37. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
38. Makuch RW: Adjusted survival curve estimation using covariates. J Chronic Dis 33:437-443, 1982
39. Chang IM, Gelman R, Pagano M: Corrected group prognostic curves and summary statistics. J Chronic Dis 35:669-674, 1982
40. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
41. Ball JK, Elixhauser A: Treatment differences between blacks and whites with colorectal cancer. Med Care 34:970-984, 1996
42. Cooper GS, Yuan Z, Rimm AA: Racial disparity in the incidence and case-fatality of colorectal cancer: Analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev 6:283-285, 1997
43. Page WF, Kuntz AJ: Racial and socioeconomic factors in cancer survival: a comparison of Veterans Administration results with selected studies. Cancer 45:1029-1040, 1980
44. Keirn W, Metter G: Survival of cancer patients by economic status in a free care setting. Cancer 55:1552-1555, 1985
45. Dominitz JA, Samsa GP, Landsman P, et al: Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82:2312-2320, 1998
46. Chen VW, Fenoglio-Preiser CM, Wu XC, et al: Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 6:1087-1093, 1997
47. Chen VW, Correa P, Kurman RJ, et al: Histologic characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3:127-135, 1994
48. Hill HA, Coates RJ, Austin H, et al: Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol 56:154-163, 1995
49. Nelson RL, Dollear T, Freels S, et al: The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 80:193-197, 1997
50. Johnson H, Carstens R: Anatomical distribution of colonic carcinomas: interracial differences in a community hospital population. Cancer 58:997-1000, 1986
51. Amato A, Pescatori M, Butti A: Local recurrence following abdominoperineal excision and anterior resection for rectal carcinoma. Dis Colon Rectum 34:317-322, 1991
52. Marusch F, Koch A, Schmidt U, et al: Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg 88:1397-1402, 2001
53. Lazovich D, White E, Thomas DB, et al: Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433-3438, 1991
54. Satariano ER, Swanson GM, Moll PP: Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health 82:195-198, 1992
55. Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097-1101, 1992
56. Michalski TA, Nattinger AB: The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer 79:314-319, 1997
57. Remington RD: Who should code cause of death in a clinical trial? Control Clin Trials 5:241-244, 1984
58. Messite J, Stellman SD: Accuracy of death certificate completion: The need for formalized physician training. JAMA 275:794-796, 1996
59. Minino AM, Smith BL: Deaths: Preliminary data for 2000. National vital statistics reports. Vol 49, No 12. Hyattsville, MD, National Center for Health Statistics, 2001
60. Diehr P, Yergan J, Chu J, et al: Treatment modality and quality differences for black and white breast cancer patients treated in community hospitals. Med Care 27:942-958, 1989
61. Harlan L, Brawley O, Pommerenke F, et al: Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 13:93-100, 1995
62. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
63. Roetzheim RG, Gonzalez EC, Ferrante JM, et al: Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 89:2202-2213, 2000
64. Liff JM, Chow WH, Greenberg RS: Rural-urban differences in stage at diagnosis: Possible relationship to cancer screening. Cancer 67:1454-1459, 1991
65. Troisi RJ, Freedman AN, Devesa SS: Incidence of colorectal carcinoma in the U.S. Cancer 85:1670-1676, 1999
66. Borum ML: Colorectal cancer surveillance in African-American and white patients at an urban university medical center. J Natl Med Assoc 91:505-508, 1999
67. Tejeda HA, Green SB, Trimble EL, et al: Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88:812-816, 1996